2. Academic Validation
  3. New coumarins and anti-inflammatory constituents from the fruits of Cnidium monnieri

New coumarins and anti-inflammatory constituents from the fruits of Cnidium monnieri

  • Int J Mol Sci. 2014 May 28;15(6):9566-78. doi: 10.3390/ijms15069566.
Tzong-Huei Lee 1,  Yuan-Chih Chen 2,  Tsong-Long Hwang 3,  Chih-Wen Shu 4,  Ping-Jyun Sung 5,  Yun-Ping Lim 6,  Wen-Lung Kuo 7,  Jih-Jung Chen 8
Affiliations

Affiliations

  • 1 Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei 110, Taiwan. thlee@tmu.edu.tw.
  • 2 Department of Pharmacy & Graduate Institute of Pharmaceutical Technology, Tajen University, Pingtung 907, Taiwan. cute88883333@yahoo.com.tw.
  • 3 Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan. htl@mail.cgu.edu.tw.
  • 4 Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan. cwshu@vghks.gov.tw.
  • 5 National Museum of Marine Biology and Aquarium, Pingtung 944, Taiwan. pjsung@nmmba.gov.tw.
  • 6 School of Pharmacy, College of Pharmacy, China Medical University, Taichung 404, Taiwan. limyp@mail2000.com.tw.
  • 7 Chung-Jen College of Nursing, Health Science and Management, Chiayi 600, Taiwan. m049@cjc.edu.tw.
  • 8 Department of Pharmacy & Graduate Institute of Pharmaceutical Technology, Tajen University, Pingtung 907, Taiwan. jjchen@tajen.edu.tw.
PMID: 24879527 DOI: 10.3390/ijms15069566
Abstract

The fruit of Cnidium monnieri is commercially used as healthcare products for the improvement of impotence and skin diseases. Three new Coumarins, 3'-O-methylmurraol (1), rel-(1'S,2'S)-1'-O-methylphlojodicarpin (2), and (1'S,2'S)-1'-O-methylvaginol (3), have been isolated from the fruits of C. monnieri, together with 14 known compounds (4-17). The structures of these new compounds were determined through spectroscopic and MS analyses. Compounds 1, 4-12, and 14-17 exhibited inhibition (IC50 ≤ 7.31 µg/mL) of superoxide anion generation by human neutrophils in response to formyl-l-methionyl-l-leucyl-l-phenylalanine/cytochalasin B (fMLP/CB). Compounds 7, 9-11, 15, and 17 inhibited fMLP/CB-induced Elastase release with IC50 values ≤7.83 µg/mL. This investigation reveals that bioactive isolates (especially 6, 7, 14, and 17) could be further developed as potential candidates for the treatment or prevention of various inflammatory diseases.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z